Moreover, mRNA-based approaches delivering TNFSF14 directly into dendritic cells or effector T cells may further amplify its immunostimulatory effect and help reshape an immune “cold” tumor into a “hot” one, rendering CRC more responsive to immune checkpoint blockade (62). The gene discussed is TNFSF14; the disease is neoplasm.